Long‐term treatment with empagliflozin as add‐on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 665-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?

By Grauslund Jakob   Rasmussen Lars M.   Green Anders   Sjølie Anne K.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 3, 2010-04 ,pp. : 188-193

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

By Seino Yutaka   Fujita Tetsuya   Hiroi Shinzo   Hirayama Masashi   Kaku Kohei  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1781-1792

Informa Healthcare

Access to resources Recommend Favorite

Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

By Chalmers J.   Hunter J. E.   Robertson S. J.   Baird J.   Martin M.   Franks C. I.   Whately-Smith C. R.   Mariz S.   Campbell I. W.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1775-1781

Informa Healthcare

Access to resources Recommend Favorite

Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite